Liming Wang
Impact in
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Hepatology top 5%
Papers in
-
- Glycosylation and Glycoproteins Research 9
- RNA modifications and cancer 6
- Extracellular vesicles in disease 6
- Oncology 23
- Cancer Cells and Metastasis 6
- Cancer-related Molecular Pathways 6
- Co-authors
- Deguang Sun (20 shared papers)Qingqiang Yao (7 shared papers)Mingliang Ye (15 shared papers)Chengyong Dong (13 shared papers)Sipra Banerjee (3 shared papers)Keqiu Jiang (9 shared papers)Zeli Yin (10 shared papers)Zhenming Gao (14 shared papers)
- Journals
- PLoS ONE (5 papers)Journal of Proteome Research (4 papers)Oncotarget (4 papers)PROTEOMICS (3 papers)RSC Advances (3 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Liming Wang
119 papers receiving 3.4k citations
Peers
Comparison fields: 5 of 128
- Cancer Research 619
- Hepatology 214
- Molecular Biology 1.6k
- Oncology 506
- Geriatrics and Gerontology 47
Countries citing papers authored by Liming Wang
This map shows the geographic impact of Liming Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liming Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liming Wang more than expected).
Fields of papers citing papers by Liming Wang
This network shows the impact of papers produced by Liming Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liming Wang. The network helps show where Liming Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Liming Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 126 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 220 | |
| 2 | 2013 | 212 | |
| 3 | 2020 | 139 | |
| 4 | 2019 | 135 | |
| 5 | 2004 | 104 | |
| 6 | 2018 | 101 | |
| 7 | DNA polymerase beta mutations in human colorectal cancer. | 1992 | 96 |
| 8 | 2017 | 92 | |
| 9 | 2020 | 80 | |
| 10 | 2014 | 75 | |
| 11 | 2016 | 70 | |
| 12 | 2019 | 70 | |
| 13 | 2018 | 66 | |
| 14 | 2014 | 66 | |
| 15 | 2010 | 65 | |
| 16 | 2018 | 59 | |
| 17 | 2007 | 57 | |
| 18 | 2015 | 52 | |
| 19 | 2019 | 47 | |
| 20 | 2017 | 47 |
About Liming Wang
Liming Wang is a scholar working on Molecular Biology, Oncology, Cancer Research, Surgery and Immunology, having authored 126 papers that have together received 3.4k indexed citations. Recurring topics across this work include Glycosylation and Glycoproteins Research (9 papers), Advanced Proteomics Techniques and Applications (9 papers), Cancer-related molecular mechanisms research (8 papers), Osteoarthritis Treatment and Mechanisms (6 papers), Cancer Cells and Metastasis (6 papers), Cancer-related Molecular Pathways (6 papers), RNA modifications and cancer (6 papers) and Extracellular vesicles in disease (6 papers). The work is most often cited by research in Cancer Research (619 citations), Hepatology (214 citations), Molecular Biology (1.6k citations), Oncology (506 citations) and Geriatrics and Gerontology (47 citations). Liming Wang has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Deguang Sun, Qingqiang Yao, Mingliang Ye, Chengyong Dong, Sipra Banerjee, Keqiu Jiang, Zeli Yin, Zhenming Gao, Cuijun Deng and Chengtie Wu. Their work appears in journals such as PLoS ONE, Journal of Proteome Research, Oncotarget, PROTEOMICS and RSC Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.